§ Funding Round
Series C funding round for EpimAb Biotherapeutics raising $120M in March 2021
Series C funding round for EpimAb Biotherapeutics raising $120M in March 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Angel | adrian cheng | |
tony rongLEAD | Angel | tony rong |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
sungwon songLEAD | Angel | sungwon song |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$219M
Top Valuation
-
EpimAb Biotherapeutics raised $120M in a Series C round.
The round was announced on 03/01/21.
The round was led by tony rong, sungwon song.
